Arkolith/Insider Trading/CRNX/Form 4

Struthers Richard Scott

President & CEO, DirectorCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$822K
Net Open-Market Flow
-$822K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)13K$37.11$490K414K
Mar 16, 2026Sell(S)9K$37.77$332K405K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-019488) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML